Main > A1. CORP. INDEX. U-Um > UCB /P C2

---

This data is not available for free

UCB /P C2's subsections
2005. 05.23.2005. Lonza
2005. 09.05.2005. Contract Mfg Sale
2006. 01.08.2006. Pierre Fabre
2006. 10.02.2006. CEO
2008. 01.21.2008. Entelos - RA
2008. 10.27.2008. Sr VP R&D
2009. 08.27.2009. Rheuma.>SLE
2010. 12.22.2010. Crohns D. & RA
2011. 06.29.2011. Harvard
2012. 01.25. Neuro.>Epilepsy Le
2012. 03.19.2012. Oxford Uni.
2012. 06.18.2012. Harvard
2012. 09.26.2012. Rheuma.>RA Oloki
2012. 12.25.2012. Neuro.>PD & RLS
2012. 12.25.2012. Rheuma.>RA Certo
2013. 02.11.2013. Osteoporosis
2013. 02.21.2013. ConfometRx
2013. 02.26.2013. Neuro.>PD
2013. 03.05. Neuro.>Epilepsy La
2013. 07.10. Kremers Urban Pharma.
2013. 09.30. Psoriasis>PsA
2013. 10.18. Rheuma.>axSpA & AS
2014. 03.11. Sanofi
2014. 04.03. Weill Cornell
2015. 01.16. NeuroPore Therapies
2017. 09.15. Neuro.>Epilepsy B
2019. 05.20. Neuro.>Epilepsy M
2020. 06.05. Neuro.>Epilepsy
2020. 07.29. Neuro.>AD.>Ab.>Roche
2022. 01.19. Acq. Zogenix
2022. 02.17. Derma.>Psoriasis>CA>OK
2022. 03.07. Acq. Zogenix
2022. 03.28. Neuro.>Epilepsy>LGS
2023. 06.27. Neuro.>gMG>USA>OK
2023. 07.21. Neuro.>gMG>USA>Launch
2023. 10.17. gMG>USA>Approved
2023. 10.18. Plaque Psoriasis>USA>O
Cepa Schwartz Pharma/P
Chiroscience Ltd./P
Patents
Schwartz Pharma/P
UCB Farchim/P
UCB Pharmaceuticals/P
UCB UK C2
Web-Site
Z - OK

UCB /P C2's products
This section has no products